Blood cancer Clinical Trials in Boston, MA

As of July 2026, 138 paid clinical trials are recruiting for Blood cancer in Boston, Massachusetts. Blood cancer trials investigate CAR-T cell therapies, bispecific antibodies, BTK and BCL-2 inhibitors, and novel combinations across leukemias, lymphomas, myeloma, and myelodysplastic syndromes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 17, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

139 clinical trials for Blood cancer

·Clear filters·↓ Download CSV

SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

for Acute Myeloid Leukemia

Drug: Venetoclax

Sites in Boston +2 more locations

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: 18+

Code: NCT03113643·Phase 1·Recruiting·Listed Apr 2017

Apply to this trial

Collection of Samples and Clinical Data From Patients With Amyloid Diseases

for Multiple Myeloma

1 location in Boston

Sponsor: Boston Medical Center

Sex: All·Age: 18+

Code: NCT00898235·Recruiting·Listed May 2009

Apply to this trial

Emapalumab Prevention of CAR-T Cell Associated Toxicities

for Large B-cell Lymphoma

2 locations in Boston

Sponsor: Marcela V. Maus, M.D.,Ph.D.

Sex: All·Age: 18+

Code: NCT06550141·Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

IS-free Treg HaploHCT

for Stem Cell Transplant Complications

1 location in Boston

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: 18 - 75

Code: NCT04678401·Phase 1·Recruiting·Listed Dec 2020

Apply to this trial

BMT-CARE: Psychosocial Intervention for Transplant Caregivers

for Bone Marrow Transplant Complications

Sites in Boston +2 more locations

Sponsor: Massachusetts General Hospital

Sex: All·Age: 18+

Code: NCT06472089·Recruiting·Listed Jun 2024

Apply to this trial

I Can Move With Purpose Now! A Pilot Lifestyle Intervention Study in Myeloproliferative Neoplasm Patients

for Myeloproliferative Disorders

3 locations in Boston

Sponsor: Massachusetts General Hospital

Sex: All·Age: 18+

Code: NCT05842603·Recruiting·Listed May 2023

Apply to this trial

HEME Home Transfusion Program

for Leukemia

2 locations in Boston

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: 18+

Code: NCT06487247·Recruiting·Listed Jul 2024

Apply to this trial

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

for Cancer Risk

1 location in Boston

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: All ages·Accepts healthy volunteers

Code: NCT05463796·Recruiting·Listed Jul 2022

Apply to this trial

Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy

for Lymphoma

Drug: Epcoritamab

Sites in Boston +2 more locations

Sponsor: Beth Israel Deaconess Medical Center

Sex: All·Age: 18+

Code: NCT06510361·Phase 2·Recruiting·Listed Jul 2024

Apply to this trial

UPLYFT For Lymphoma Survivors

for Lymphoma

1 location in Boston

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: 18+

Code: NCT05080166·Recruiting·Listed Oct 2021

Apply to this trial

BXCL701 Phase 1 R/R Acute Myeloid Leukemia or Myelodysplastic Syndrome

for Acute Myeloid Leukemia

1 location in Boston

Sponsor: Eric Stephen Winer, MD

Sex: All·Age: 18+

Code: NCT05703542·Phase 1·Recruiting·Listed Jan 2023

Apply to this trial

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

for Hematologic Malignancy

Sites in Boston +28 more locations

Sponsor: Therapeutic Advances in Childhood Leukemia Consortium

Sex: All·Age: 1 - 21

Code: NCT05476770·Phase 1·Recruiting·Listed Jul 2022

Apply to this trial

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

for Lymphoma, Non-Hodgkin

Sites in Boston +22 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07101328·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors

for Lymphoma

1 location in Boston

Sponsor: Massachusetts General Hospital

Sex: All·Age: 18+

Code: NCT07014293·Recruiting·Listed Jun 2025

Apply to this trial

Selinexor and Backbone Treatments of Multiple Myeloma Patients

for Multiple Myeloma

Drug: Selinexor

Sites in Boston +2 more locations

Sponsor: Karyopharm Therapeutics Inc

Sex: All·Age: 18+

Code: NCT02343042·Phase 1, Phase 2·Recruiting·Listed Jan 2015

Apply to this trial

AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma

for Multiple Myeloma

Sites in Boston +7 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06106945·Phase 1, Phase 2·Recruiting·Listed Oct 2023

Apply to this trial

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

for Lymphoma

Sites in Boston +6 more locations

Sponsor: AstraZeneca

Sex: All·Age: 12+

Code: NCT06137144·Phase 1, Phase 2·Recruiting·Listed Nov 2023

Apply to this trial

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

for Chronic Lymphocytic Leukaemia

Sites in Boston +11 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06564038·Phase 1, Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

Conditions in Blood cancer (Boston, MA)

Acute myeloid leukemia (AML)· 36 Non-Hodgkin lymphoma· 33 Multiple myeloma· 32 Myelodysplastic syndromes (MDS)· 21 Chronic lymphocytic leukemia (CLL)· 19 Leukemia (other)· 18 Hematologic malignancy· 16 Follicular lymphoma· 11 Small lymphocytic lymphoma· 11 Myelofibrosis· 9 Diffuse large B-cell lymphoma (DLBCL)· 9 Myeloproliferative neoplasm· 7 Mantle cell lymphoma· 7 Hodgkin lymphoma· 6 Acute lymphoblastic leukemia· 5 Marginal zone lymphoma· 5 Chronic myelomonocytic leukemia· 3 Burkitt lymphoma· 2